Open AccessThe Utilization of the Implantable Defibrillator—a European Enigma
Author(s) -
A. John Camm
Publication year - 2000
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.2000.2473
Subject(s) - medicine , implantable cardioverter defibrillator , sudden cardiac death , ventricular tachycardia , randomized controlled trial , clinical trial , ventricular fibrillation , sudden death , intensive care medicine , cardiology
In the 20 years since Michel Mirowski and coworkers implanted an ICD into their first patient, the implantable cardioverter defibrillator (ICD) has become recognized as the therapy of first choice for managing patients at high risk of sudden cardiac death from ventricular tachyarrhythmias. Multiple clinical series and recently completed prospective, randomized trials have shown that ICDs are irrefutably superior to antiarrhythmic drugs in reducing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom